As Covid disrupts medical care, Peninsula company aims $14M round at plugging a genetics gap

Hoping to capitalize on the shift to virtual medical care as Covid-19 rages on, Genome Medical Inc. said it raised $14 million to guide patients to the care and testing they need and to help hospitals triage a backlog. The South San Francisco company said it is accelerating the rollout of a technology backbone meant to walk patients through the process of whether they need genetic testing and other services. It initially will target reproductive health, starting this month, and extend to cancer…